Characteristics of innate, humoral and cellular immunity in children with non-severe SARS-CoV-2 infection

Copyright © 2023. Published by Elsevier Ltd..

The symptoms of children infected with SARS-CoV-2 are mainly asymptomatic, mild, moderate, and a few severe cases. To understand the immune response characteristics of children infected with SARS-COV-2 who do not develop severe cases, 82 children infected with the SARS-CoV-2 delta strain were recruited in this study. Our results showed that high levels of IgG, IgM, and neutralization antibodies appeared in children infected with SARS-CoV-2. SARS-CoV-2 induced upregulation of both pro-inflammatory factors including TNF-α and anti-inflammatory factors including IL-4 and IL-13 in the children, even IL-10. The expression of INF-α in infected children also showed a significant increase compared to healthy children. However, IL-6, one of the important inflammatory factors, did not show an increase in infected children. It is worth noting that a large number of chemokines reduced in the SARS-CoV-2-infected children. Subsequently, TCR Repertoire, TCRβ bias, and preferential usage were analyzed on data of TCR next-generation sequencing from 8 SARS-CoV-2-infected children and 8 healthy controls. We found a significant decrease in TCR clonal diversity and a significant increase in TCR clonal expansion in SARS-CoV-2-infected children compared to healthy children. The most frequent V and J genes in SARS-CoV-2 children were TRBV28 and TRBJ2-1. The most frequently VβJ gene pairing in SARS-CoV-2 infected children was TRBV20-1-TRBJ2-1. The strong antiviral antibody levels, low expression of key pro-inflammatory factors, significant elevation of anti-inflammatory factors, and downregulation of many chemokines jointly determine that SARS-CoV-2-infected children rarely develop severe cases. Overall, our findings shed a light on the immune response of non-severe children infected with SARS-CoV-2.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:88

Enthalten in:

The Journal of infection - 88(2024), 2 vom: 22. Feb., Seite 158-166

Sprache:

Englisch

Beteiligte Personen:

Zong, Kexin [VerfasserIn]
Yuan, Ping [VerfasserIn]
Wang, Ruifang [VerfasserIn]
Luo, Qin [VerfasserIn]
Yang, Yanqing [VerfasserIn]
Zhang, Xiaohong [VerfasserIn]
Song, Qinqin [VerfasserIn]
Du, Haijun [VerfasserIn]
Gao, Chen [VerfasserIn]
Song, Juan [VerfasserIn]
Zhan, Weihua [VerfasserIn]
Zhang, Mengjie [VerfasserIn]
Wang, Yanhai [VerfasserIn]
Lin, Qunying [VerfasserIn]
Yao, Hailan [VerfasserIn]
Xie, Baosong [VerfasserIn]
Han, Jun [VerfasserIn]

Links:

Volltext

Themen:

Anti-Inflammatory Agents
Antibodies, Viral
Antibody protection
Chemokines
Children
Cytokines and chemokines
Journal Article
Receptors, Antigen, T-Cell
SARS-CoV-2
TCR repertoire

Anmerkungen:

Date Completed 07.02.2024

Date Revised 07.02.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.jinf.2023.12.003

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM365922137